Author Page

Author Archives: Roy Trevelion

The Camden New Journal (CNJ) have published the sixth article about the NHS written by Susanna Mitchell and Roy Trevelion. You can see it on the CNJ website under ‘Forum’ published on 16 July 2020 here. Or you can read it below: Neglect and inadequate excuses lie at the heart of the government’s failures, argue Susanna Mitchell & Roy Trevelion It is understood that there will be a public inquiry into the UK’s handling of the coronavirus pandemic. This should begin now, and not when the current crisis is over. Criticisms will be focused on the government’s disastrous response: Its […]
Read More

On Friday 24 July 2020 HIV i-Base published the sixth COVID-19 supplement to HIV Treatment Bulletin (HTB). Please see this link. All i-Base reports are free to copy and i-Base encourages wide distribution. Please credit i-Base when distributing these reports. This is a slightly expanded issue of HTB that covers both AIDS 2020 and related virtual meetings plus a fair number of COVID-19 developments that seemed too important to leave out. It is a mixed compilation, but hopefully useful. This edition of HTB includes reports from the virtual AIDS 2020 conference and linked satellite meetings on COVID-19. The main heading […]
Read More

Kay Marshall (from AVAC) and Richard Jefferys (from TAG) call on organisations working in health and social care to sign in support of their statement on human challenge studies for COVID-19 vaccine development. Richard Jefferys writes: TAG and AVAC are circulating this statement and seeking endorsements from organizations that agree with our position:  https://forms.gle/xatyJBaePmbh25Pw7 As background, challenge trials involve deliberate exposure to a pathogen in order to test vaccines. Typically they involve pathogens for which treatments are available (malaria challenge studies are probably the best known example). A human challenge with SARS-CoV-2 would obviously be very different given the lack […]
Read More

The UK-CAB is the UK’s HIV treatment advocates network.   A couple of weeks ago four UK-CAB members spoke to Dr Rageshri Dhairyawan from Barts Health NHS Trust. It was a chance for HIV positive people from BAME communities to voice their concerns about the coronavirus pandemic. The strong focus was on questions from people living with HIV and the communities they work in. Watch via YouTube: https://youtu.be/Cy7d7FD2ro0 The recording is about 40 minutes long. It covers a wide range of questions in relation to COVID-19. Discussion covers inequalities in health care, sexual health, mental health, research, stigma and HIV treatment.    We hope […]
Read More

HIV charities, community groups, health professionals and activists have today written to Matt Hancock, Secretary of State for Health and Social Care. They write to express their profound concern at the decision to roll back the Secretary of State’s commitment on PrEP (Pre-Exposure Prophylaxis for HIV) in England. Last week it was announced that the budget provided to local authorities for the implementation of PrEP would be reduced from £16 million to £11 million. The letter says this budget cut for PrEP jeopardises the ability to fully roll-out the most powerful prevention tool to help fulfil Mr Hancock’s commitment to […]
Read More

On Friday 26 June 2020 HIV i-Base published the fifth COVID-19 supplement to HIV Treatment Bulletin (HTB). Please see this link. All i-Base reports are free to copy and i-Base encourages wide distribution. Please credit i-Base when distributing these reports.   HIV and COVID-19: a new supplement to HIV Treatment Bulletin (HTB). This publication reviews the latest news on COVID-19, including research that is important for care of people living with HIV. All articles are online as html web pages. The PDF files use a single column layout that makes it easy to read each issue on tablets and other hand […]
Read More

The degree of failure in this study is not an unfortunate scientific event. It is a terrible failure, reports Simon Collins at HIV i-Base.  Simon Collins, HIV i-Base On 5 June 2020, the large randomised RECOVERY study announced that hydroxychloroquine (HCQ) will no longer be used to treat COVID-19. [1] The results show that hundreds of people died – both taking HCQ and in the comparison group receiving no investigational drugs – and yet the study was only closed because of a safety request by the UK Medicines and Healthcare products Regulatory Agency (MHRA). This very large study – with […]
Read More

BASHH (The British Association for Sexual Health and HIV) reports significantly reduced service capacity during the coronavirus pandemic. They are monitoring this with an ongoing survey. Here is the most recent set of results dated 21 April 2020. You can click through to read the full results on the link below or on the BASHH site. The British Association for Sexual Health and HIV (BASHH) are running an ongoing survey during the coronavirus pandemic to understand how sexual health services are being impacted and where pressures are emerging. The most recent set of results found that service capacity has been significantly […]
Read More

The May 2020 issue of the Sexual Health, Reproductive Health & HIV Policy eBulletin is out today. It contains updates on the sector’s response to the COVID-19 pandemic.  In the eFeature, Dame Inga Beale, Chair of the HIV Commission, talks about her work to meet the UK’s target of no new HIV transmissions by 2030 despite the significant whole system and personal challenges presented by the COVID-19 pandemic. She highlights the value of continued engagement with the Commission as it pushes ahead with further evidence gathering. Meanwhile, this month’s roundup brings together developing COVID-19 guidance and resources that have been produced […]
Read More

US President Donald Trump has said he is taking hydroxychloroquine to ward off coronavirus, despite public health officials warning it may be unsafe. Please see this report from Simon Collins at HIV i-Base in the 14 May COVID-19 supplement to HTB (HIV Treatment Bulletin). Here is the report: Simon Collins, HIV i-Base Several studies have recently reported a lack of benefit from using hydroxychloroquine (HCQ) to treat COVID-19, with or without use of azithromycin (AZ).  These results challenge a controversial French study reported that an initial benefit that led to more than 100 new studies investigating this potential treatment, including […]
Read More

The attached advice from the Faculty of Sexual and Reproductive Health provides details about the changes to provision of sexual and reproductive healthcare during COVID-19. It includes what type of care women can expect and how to get it – for example, how to get normal contraception prescriptions or treatment during the pandemic.   A link to the document is provided below, and a copy is also attached. FSRH has launched a comprehensive advice document for women seeking sexual and reproductive healthcare during the COVID-19 pandemic. The advice aims to inform and empower women to make the best choices for their sexual and reproductive […]
Read More

Many migrants, refugees, and people with insecure immigration status in the UK will be particularly at risk during Coronavirus, due to lack of or restricted access to council services, healthcare, and housing. JCWI, Migrants Organise, and Medact have put together a short guide for Mutual Aid groups to consider how best to support at risk migrants. Please share this far and wide! https://docs.google.com/document/d/11cKMCy08ebN-lJQsP1jvsTcSfwC6YeE8FYrmAZCoZ1w/mobilebasic   Some resources and information from the guide Docs Not Cops health rights advice Advice from NHS 111, and treatment in a GP surgery or A&E department, are always free There is no charge for examinations or tests […]
Read More